Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


12.07.2021

4 Aliment Pharmacol Ther
1 BMC Gastroenterol
2 Clin Gastroenterol Hepatol
2 Gastroenterology
5 J Clin Gastroenterol
4 J Crohns Colitis
1 Lancet
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. HONAP S, Pavlidis P, Irving PM
    Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?
    Aliment Pharmacol Ther. 2021;54:341-342.
    PubMed        

  2. MCGING JJ, Radford SJ, Francis ST, Serres S, et al
    Review article: The aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies.
    Aliment Pharmacol Ther. 2021 Jul 6. doi: 10.1111/apt.16465.
    PubMed         Abstract available

  3. LUBER RP, O'Neill R, Singh S, Sharma E, et al
    An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
    Aliment Pharmacol Ther. 2021 Jul 5. doi: 10.1111/apt.16497.
    PubMed         Abstract available

  4. ROTONDO-TRIVETTE S, Wang B, Gayer C, Parsana R, et al
    Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection.
    Aliment Pharmacol Ther. 2021 Jul 4. doi: 10.1111/apt.16496.
    PubMed         Abstract available


    BMC Gastroenterol

  5. CROTHERS JW, Chu ND, Nguyen LTT, Phillips M, et al
    Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.
    BMC Gastroenterol. 2021;21:281.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  6. CHAN SSM, Chen Y, Casey K, Olen O, et al
    Obesity is associated with increased risk of Crohn's disease, but not ulcerative colitis: A pooled analysis of five prospective cohort studies.
    Clin Gastroenterol Hepatol. 2021 Jul 6. pii: S1542-3565(21)00720.
    PubMed         Abstract available

  7. NARULA N, Wong ECL, Colombel JF, Riddell R, et al
    Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2021 Jul 3. pii: S1542-3565(21)00716.
    PubMed         Abstract available


    Gastroenterology

  8. BEN-TOV A, Banon T, Chodick G, Kariv R, et al
    BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.
    PubMed        

  9. LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
    Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
    Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
    PubMed         Abstract available


    J Clin Gastroenterol

  10. HAIDER M, Lashner B
    Dual Targeted Therapy for the Management of Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Jul 8. pii: 00004836-900000000-97396.
    PubMed         Abstract available

  11. DOLINGER MT, Choi JJ, Phan BL, Rosenberg HK, et al
    Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn's Disease.
    J Clin Gastroenterol. 2021;55:429-432.
    PubMed         Abstract available

  12. HASHASH JG, Beatty PL, Critelli K, Hartman DJ, et al
    Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative Crohn's Disease.
    J Clin Gastroenterol. 2021;55:127-133.
    PubMed         Abstract available

  13. KOCHAR B, Jiang Y, Long MD
    Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.
    J Clin Gastroenterol. 2021;55:350-354.
    PubMed         Abstract available

  14. CHANDAN S, Mohan BP, Kumar A, Khan SR, et al
    Safety and Efficacy of Biological Therapy in Chronic Antibiotic Refractory Pouchitis: A Systematic Review With Meta-analysis.
    J Clin Gastroenterol. 2021;55:481-491.
    PubMed         Abstract available


    J Crohns Colitis

  15. DINALLO V, Di Fusco D, Di Grazia A, Laudisi F, et al
    The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 7. pii: 6316763. doi: 10.1093.
    PubMed         Abstract available

  16. CHOI WT, Salomao M, Zhao L, Alpert L, et al
    Hypermucinous, Goblet Cell Deficient, and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    J Crohns Colitis. 2021 Jul 7. pii: 6316756. doi: 10.1093.
    PubMed         Abstract available

  17. DELISLE M, Wilkens R, Novak KL
    Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index.
    J Crohns Colitis. 2021 Jul 5. pii: 6315708. doi: 10.1093.
    PubMed        

  18. RESTELLINI S, Lakatos PL
    Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle.
    J Crohns Colitis. 2021;15:1085-1086.
    PubMed        


    Lancet

  19. SMERAT T, Khdour M, Abdoh Q, Hallak H, et al
    Assessment of health-related quality of life in patients with inflammatory bowel disease in occupied Palestinian territory: a correlation cross-sectional study.
    Lancet. 2021;398 Suppl 1:S48.
    PubMed         Abstract available


    PLoS One

  20. KATO M, Sugimoto K, Ikeya K, Takano R, et al
    Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.
    PLoS One. 2021;16:e0254548.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: